No Data
Earlier session / Active stocks and traded stocks [Active stocks and traded stocks]
*Daisue Construction <1814> 1962 +157 viewed as a Buy due to a significant Shareholding. *Tanseisha <9743> 1116 +66 continues to be positively received for its forecast of double-digit profit growth and planned dividend increase. *Yamashin Filter <6240> 631 +31 also has pointers such as the quarterly report. *Taiyo Yuden <6976> 2673 +131 is particularly lacking in materials, making short covering a dominant trend. *IHI <7013> 11790 +520 expansion in private aviation engine Components.
Stocks with a limit-up or limit-down in the afternoon session.
■ Limit Up <218A> Liberaware <2459> Aun Consulting <3987> Ecomott <5136> Tripla <5721> S-Science <6085> Architects Studio Japan <6769> Zain Electronics <9743> Tanseisha ■ Limit Down <184A> Manabi Aid <9279> Gift Holdings * Includes temporary Limit Up and Down (indicative values).
Manabi-aid: (Correction) Partial Corrections to the “Financial Results Explanatory Materials for the 3rd Quarter Ending April 2025”
<Today's individual materials> FIXER, Otsuka HD, Tanaka Chemical Research, Manabi Aid, ETC (announced on the 17th)
▽ FIXER <5129.T> has entered into a basic agreement to establish a joint venture with Fujita Gakuen (Toyooki City, Aichi Prefecture), which operates Universities and Hospitals. ▽ Otsuka HD <4578.T>, through its subsidiary Daiho Pharmaceutical Industry, has agreed to fully acquire Swiss-based Araris Biotech. ▽ Tanaka Chemical Research <4080.T> has lowered its standalone financial estimates for the fiscal year ending March 2025, revising the end-of-term Dividends forecast from 4 yen to no Dividends (previous period's achievement was 4 yen). ▽ Manabi Aid <184A.T> has made a downward revision to its standalone financial estimates for the fiscal year ending April 2025.
tripla, Daiwa Cycle and others
＜184A＞ The revised forecast for the learning aid has been adjusted downward, with an operating loss outlook of △0.299 billion yen, down from 0.2 billion yen. ＜286A＞ Acquired stocks of Gplus, which engages in Yukaria A-REIT ETF inheritance consulting, making it a wholly-owned subsidiary. ＜4014＞ Concluded a memorandum regarding the consideration of a business partnership with Sumitomo Life Insurance Mutual Company, which operates in the Insurance business. ＜4169＞ Recorded a subsidy income from Enechange of 4.676 billion yen as non-operating income. ＜4591＞ Ribomic JST・CREST "AI App.
Tanaka Chemical Research, revised deficit for 25/3 operating loss of -0.45 billion yen from -0.9 billion yen.
Tanaka Chemical Research Co., Ltd. <4080> announced a revision of its financial estimates for the fiscal year ending March 2025. Revenue has been revised down from 38 billion yen to 36 billion yen, and operating loss has been lowered from a loss of 0.9 billion yen to a loss of 0.45 billion yen. The slowdown in the growth of the EV market has significantly impacted this, with sales volumes decreasing more than expected. On the profit side, inventory valuation losses of 1.398 billion yen were recorded. 【Positive Evaluation】 <5136> tripla Four | <325A> TENTIAL Annual <3169> Misawa Annual | <3467> Agree City D Revision <